Tirzepatide (Zepbound): The Dual-Action Powerhouse Tirzepatide's dual-agonist action on both GLP-1 and GIP receptors is what makes it so compelling, often delivering slightly superior weight loss results in clinical trials
Fil-qasam tal-anti-tixji, prodotti topii gall-kura tal-ilda ilhom jiddominaw is-suq
A GLP-1/GIP dual, in the same class as Mounjaro
Women with PCOS, especially those who had irregular periods before starting GLP-1s, may take longer to establish regular cycles
Published online January 1, 1975
GLP-1 medications can be incredibly effective tools, but they work best when paired with habits that support long-term health, not just short-term weight loss